文献速递免疫规划传染病防控与疫情报告

2004至2015年荷兰侵袭性肺炎球菌疾病的性别差异及肺炎球菌结合疫苗接种的影响

Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015.
PubMed 文献 · Euro Surveill · 2017-01-01

荷兰于2006年和2011年分别为婴儿引入PCV7和PCV10后,侵袭性肺炎球菌疾病(IPD)的血清型发生转移。研究比较了疫苗接种前、PCV7后和PCV10后三个时期按年龄分层的IPD发病率,发现男性各年龄组发病率均高于女性,但20-39岁女性在PCV7后出现因血清型替换导致的暂时性发病率上升。

要点

  • 男性IPD总体发病率在三个时期均高于女性(16.7、15.5、14.4/10万 vs 15.4、13.6、13.9/10万)。
  • 20-39岁男性IPD发病率从PCV7前的5.3/10万降至PCV7后的4.7/10万和PCV10后的2.6/10万。
  • 20-39岁女性IPD发病率从PCV7前的3.9/10万暂时升至PCV7后的5.0/10万,PCV10后回落至4.0/10万。

核心结论

  • 男性IPD总体发病率在PCV7前、PCV7后和PCV10后均高于女性,但20-39岁女性在PCV7后出现因血清型替换导致的暂时性发病率上升。

研究设计与样本

  • 比较荷兰2004年6月至2006年5月(PCV7前)、2008年6月至2011年5月(PCV7后)和2013年6月至2015年5月(PCV10后)三个时期按年龄分层的IPD发病率。

主要发现

  • 男性IPD总体发病率在PCV7前、PCV7后和PCV10后分别为16.7、15.5和14.4/10万,女性分别为15.4、13.6和13.9/10万。
  • 20-39岁男性IPD发病率从PCV7前的5.3/10万降至PCV7后的4.7/10万和PCV10后的2.6/10万。
  • 20-39岁女性IPD发病率从PCV7前的3.9/10万暂时升至PCV7后的5.0/10万,PCV10后回落至4.0/10万,原文归因于血清型替换。
  • 40岁以上女性中非PCV10血清型IPD发病率显著增加,抵消了总体IPD发病率的下降。

临床怎么用

  • 作者认为,持续按性别监测IPD发病率对于评估PCV实施的长期效果很重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Implementation of pneumococcal conjugate vaccines in the Netherlands (PCV7 in 2006 and PCV10 in 2011) for infants caused a shift in serotypes in invasive pneumococcal disease (IPD). We explored sex differences in serotype-specific IPD incidence before and after vaccine introduction. Incidences in the pre-PCV7 (June 2004-May 2006), post-PCV7 (June 2008-May 2011) and post-PCV10 period (June 2013-May 2015), stratified by age, were compared. Incidence was higher in men for all age groups (overall in men: 16.7, 15.5 and 14.4/100,000 and women: 15.4, 13.6 and 13.9/100,000 pre-PCV7, post-PCV7 and post-PCV10, respectively), except for 20-39 year-olds after PCV7 and 40-64 year-olds after PCV10 introduction. After PCV7 and PCV10 introduction, the overall IPD incidence decreased in men aged 20-39 years (from 5.3 pre-PCV7 to 4.7 and 2.6/100,000 post-PCV7 and post-PCV10, respectively), whereas it showed a temporary increase in women (from 3.9/100,000 pre-PCV7 to 5.0/100,000 post-PCV7 and back to 4.0/100,000 post-PCV10) due to replacement disease. PCV10 herd effects were observed throughout, but in women older than 40 years, a significant increase in non-PCV10 serotype offset a decrease in overall IPD incidence. Ongoing surveillance of IPD incidence by sex is important to evaluate the long-term effects of PCV implementation.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Wagenvoort GH, Sanders EA, Vlaminckx BJ, et al. Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015. Euro Surveill. 2017. PMID: 28300529. doi:10.2807/1560-7917.ES.2017.22.10.30481

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。